{"title": "With single gene insertion, blind mice regain sight", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/genes.xml", "value": "With single gene insertion, blind mice regain sight"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190315095808.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190315095808.htm", "summary": "People left blind by retinal degeneration have one option: electronic eye implants. Neuroscientists have now developed an alternative: gene therapy that, in tests, restored vision in blind mice. A gene for green opsin delivered via virus gave blind mice enough sight to discern patterns on an iPad at a resolution sufficient for humans to read. Given existing AAV eye therapies already approved, this new therapy could be ready for clinical trials in three years.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/genes.xml", "value": "People left blind by retinal degeneration have one option: electronic eye implants. Neuroscientists have now developed an alternative: gene therapy that, in tests, restored vision in blind mice. A gene for green opsin delivered via virus gave blind mice enough sight to discern patterns on an iPad at a resolution sufficient for humans to read. Given existing AAV eye therapies already approved, this new therapy could be ready for clinical trials in three years."}, "media_thumbnail": [{"url": "https://www.sciencedaily.com/images/2019/03/190315095808-large.jpg", "height": "204", "width": "300"}], "href": "", "published": "Fri, 15 Mar 2019 09:58:08 EDT", "published_parsed": [2019, 3, 15, 13, 58, 8, 4, 74, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190315095808.htm", "guidislink": false}